{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T06:05:32Z","timestamp":1788156332447,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003785","name":"Medical Scientific Research Foundation of Guangdong Province of China","doi-asserted-by":"crossref","award":["B2025411"],"award-info":[{"award-number":["B2025411"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-04028-1","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T14:13:06Z","timestamp":1760451186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["SPOCD1 expression in clear cell renal cell carcinoma: its implications for the prognosis and immunotherapy"],"prefix":"10.1186","volume":"23","author":[{"given":"Wu","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dali","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuilian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"issue":"1","key":"4028_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","volume":"75","author":"U Capitanio","year":"2019","unstructured":"Capitanio U, Bensalah K, Bex A, et al. Epidemiology of renal cell carcinoma. Eur Urol. 2019;75(1):74\u201384. https:\/\/doi.org\/10.1016\/j.eururo.2018.08.036.","journal-title":"Eur Urol"},{"key":"4028_CR2","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.13179.1","volume":"7","author":"S Nabi","year":"2018","unstructured":"Nabi S, Kessler ER, Bernard B, et al. Renal cell carcinoma: a review of biology and pathophysiology. F1000Res. 2018;7:307. https:\/\/doi.org\/10.12688\/f1000research.13179.1.","journal-title":"F1000Res"},{"key":"4028_CR3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-pathol-012414-040306","volume":"10","author":"IJ Frew","year":"2015","unstructured":"Frew IJ, Moch H. A clearer view of the molecular complexity of clear cell renal cell carcinoma. Annu Rev Pathol. 2015;10:263\u201389.","journal-title":"Annu Rev Pathol"},{"issue":"3","key":"4028_CR4","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2018.03.077","volume":"173","author":"CJ Ricketts","year":"2018","unstructured":"Ricketts CJ, Linehan WM. Multi-regional sequencing elucidates the evolution of clear cell renal cell carcinoma. Cell. 2018;173(3):540\u20132.","journal-title":"Cell"},{"key":"4028_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ctrv.2017.08.010","volume":"60","author":"A Sanchez-Gastaldo","year":"2017","unstructured":"Sanchez-Gastaldo A, Kempf E, Gonzalez Del Alba A, et al. Systemic treatment of renal cell cancer: a comprehensive review. Cancer Treat Rev. 2017;60:77\u201389. https:\/\/doi.org\/10.1016\/j.ctrv.2017.08.010.","journal-title":"Cancer Treat Rev"},{"key":"4028_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ctrv.2018.07.009","volume":"70","author":"MB Atkins","year":"2018","unstructured":"Atkins MB, Tannir NM. Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma. Cancer Treat Rev. 2018;70:127\u201337. https:\/\/doi.org\/10.1016\/j.ctrv.2018.07.009.","journal-title":"Cancer Treat Rev"},{"issue":"7","key":"4028_CR7","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nrneph.2017.59","volume":"13","author":"HI Wettersten","year":"2017","unstructured":"Wettersten HI, Aboud OA, Lara PN, et al. Metabolic reprogramming in clearcell renal cell carcinoma. Nat Rev Nephrol. 2017;13(7):410\u20139. https:\/\/doi.org\/10.1038\/nrneph.2017.59.","journal-title":"Nat Rev Nephrol"},{"issue":"40","key":"4028_CR8","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1038\/s41388-018-0315-z","volume":"37","author":"H Miess","year":"2018","unstructured":"Miess H, Dankworth B, Gouw AM, et al. The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal. Cell Carcinoma Oncogene. 2018;37(40):5435\u201350. https:\/\/doi.org\/10.1038\/s41388-018-0315-z.","journal-title":"Cell Carcinoma Oncogene"},{"issue":"1","key":"4028_CR9","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1038\/s41467-019-09277-9","volume":"10","author":"Y Zou","year":"2019","unstructured":"Zou Y, Palte MJ, Deik AA, et al. A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis. Nat Commun. 2019;10(1):1617. https:\/\/doi.org\/10.1038\/s41467-019-09277-9.","journal-title":"Nat Commun"},{"key":"4028_CR10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41586-020-2557-5","volume":"584","author":"A Zoch","year":"2020","unstructured":"Zoch A, Auchynnikava T, Berrens RV, Kabayama Y, Sch\u00f6pp T, Heep M, Vasiliauskait\u02d9e L, P\u00e9rez-Rico YA, Cook AG, Shkumatava A, et al. SPOCD1 is an essential executor of piRNA-directed de Novo DNA methylation. Nature. 2020;584:635\u20139.","journal-title":"Nature"},{"key":"4028_CR11","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1053\/j.gastro.2017.02.017","volume":"152","author":"M Zhu","year":"2017","unstructured":"Zhu M, Yan C, Ren C, Huang X, Zhu X, Gu H, Wang M, Wang S, Gao Y, Ji Y, et al. Exome array analysis identifies variants in SPOCD1 and BTN3A2 that affect risk for gastric cancer. Gastroenterology. 2017;152:2011\u201321.","journal-title":"Gastroenterology"},{"key":"4028_CR12","first-page":"624","volume":"8","author":"Q Liu","year":"2018","unstructured":"Liu Q, Wang XY, Qin YY, Yan XL, Chen HM, Huang QD, Chen JK, Zheng JM. SPOCD1 promotes the proliferation and metastasis of glioma cells by up-regulating PTX3. Am J Cancer Res. 2018;8:624\u201335.","journal-title":"Am J Cancer Res"},{"key":"4028_CR13","first-page":"3218","volume":"17","author":"J Liang","year":"2018","unstructured":"Liang J, Zhao H, Hu J, Liu Y, Li Z. Spocd1 promotes cell proliferation and inhibits cell apoptosis in human osteosarcoma. Mol Med Rep. 2018;17:3218\u201325.","journal-title":"Mol Med Rep"},{"key":"4028_CR14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejca.2016.06.003","volume":"64","author":"AG van der Heijden","year":"2016","unstructured":"van der Heijden AG, Mengual L, Lozano JJ, Ingelmo-Torres M, Ribal MJ, Fern\u00e1ndez PL, Oosterwijk E, Schalken JA, Alcaraz A, Witjes JA. A five-gene expression signature to predict progression in T1G3 bladder cancer. Eur J Cancer. 2016;64:127\u201336.","journal-title":"Eur J Cancer"},{"key":"4028_CR15","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284\u20137.","journal-title":"OMICS"},{"key":"4028_CR16","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39:782\u201395.","journal-title":"Immunity"},{"issue":"W1","key":"4028_CR17","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, et al. TIMER2.0 for analysis of Tumor-Infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509\u201314. https:\/\/doi.org\/10.1093\/nar\/gkaa407.","journal-title":"Nucleic Acids Res"},{"issue":"Pt 2","key":"4028_CR18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.semcancer.2018.05.004","volume":"52","author":"G Curigliano","year":"2018","unstructured":"Curigliano G. Gyneco-oncological genomics and emerging biomarkers for cancer treatment with immune-checkpoint inhibitors. Semin Cancer Biol. 2018;52(Pt 2):253\u20138. https:\/\/doi.org\/10.1016\/j.semcancer.2018.05.004.","journal-title":"Semin Cancer Biol"},{"key":"4028_CR19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00514","volume":"5","author":"P Italiani","year":"2014","unstructured":"Italiani P, Boraschi D. From monocytes to M1\/M2 macrophages: phenotypical vs. functional differentiation. Front Immunol. 2014;5:514.","journal-title":"Front Immunol"},{"issue":"1","key":"4028_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/ajcp\/aqx107","volume":"149","author":"C Su","year":"2017","unstructured":"Su C, Jia S, Liu H. Immunolocalization of CD163\u2009+\u2009tumor associated macrophages and symmetric proliferation of Ki-67 as biomarkers to differentiate new different grades of laryngeal dysplasia. Am J Clin Pathol. 2017;149(1):8\u201316. https:\/\/doi.org\/10.1093\/ajcp\/aqx107.","journal-title":"Am J Clin Pathol"},{"key":"4028_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19041176","volume":"19","author":"G Sammarco","year":"2018","unstructured":"Sammarco G, Gadaleta CD, Zuccal\u00e0 V, Albayrak E, Patruno R, Milella P, et al. Tumor-associated macrophages and mast cells positive to tryptase are correlated with angiogenesis in surgically-treated gastric cancer patients. Int J Mol Sci. 2018;19:19. https:\/\/doi.org\/10.3390\/ijms19041176.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"4028_CR22","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.7150\/thno.53749","volume":"11","author":"A Zhang","year":"2021","unstructured":"Zhang A, Xu Y, Xu H, Ren J, Meng T, Ni Y, Zhu Q, Zhang WB, Pan YB, Jin J, Bi Y, Wu ZB, Lin S, Lou M. Lactate-induced M2 polarization of tumor-associated macrophages promotes the invasion of pituitary adenoma by secreting CCL17. Theranostics. 2021;11(8):3839\u201352. https:\/\/doi.org\/10.7150\/thno.53749.","journal-title":"Theranostics"},{"key":"4028_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01106","volume":"8","author":"W Song","year":"2017","unstructured":"Song W, Mazzieri R, Yang T, Gobe GC. Translational significance for tumor metastasis of tumor-associated macrophages and epithelial mesenchymal transition. Front Immunol. 2017;8:1106. https:\/\/doi.org\/10.3389\/fimmu.2017.01106.","journal-title":"Front Immunol"},{"issue":"7446","key":"4028_CR24","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature12034","volume":"496","author":"TA Wynn","year":"2013","unstructured":"Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature. 2013;496(7446):445\u201355. https:\/\/doi.org\/10.1038\/nature12034.","journal-title":"Nature"},{"key":"4028_CR25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1359-6101(01)00023-5","volume":"13","author":"JM Ellery","year":"2002","unstructured":"Ellery JM, Nicholls PJ. Alternate signalling pathways from the interleukin-2 receptor. Cytokine Growth Factor Rev. 2002;13:27\u201340.","journal-title":"Cytokine Growth Factor Rev"},{"key":"4028_CR26","volume":"5","author":"B Shang","year":"2015","unstructured":"Shang B, Liu Y, Jiang SJ, Liu Y. Prognostic value of tumor-infiltrating FoxP3\u2009+\u2009regulatory T cells in cancers: a systematic review and meta analysis. Sci Rep. 2015;5:15179.","journal-title":"Sci Rep"},{"key":"4028_CR27","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/s43018-020-00133-0","volume":"1","author":"I Solomon","year":"2020","unstructured":"Solomon I, Amann M, Goubier A, et al. CD25-Treg-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity. Nat Cancer. 2020;1:1153\u201366.","journal-title":"Nat Cancer"},{"issue":"1","key":"4028_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.bbcan.2017.03.002","volume":"1868","author":"JM Spangle","year":"2017","unstructured":"Spangle JM, Roberts TM, Zhao JJ. The emerging role of PI3K\/AKT-mediated epigenetic regulation in cancer. Biochim Biophys Acta Rev Cancer. 2017;1868(1):123\u201331. https:\/\/doi.org\/10.1016\/j.bbcan.2017.03.002.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"8","key":"4028_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21081055","volume":"21","author":"MA Moga","year":"2016","unstructured":"Moga MA, Dimienescu OG, Arvatescu C, Mironescu A, Dracea L, Ples L. The role of natural polyphenols in the prevention and treatment of cervical cancer-an overview. Molecules. 2016;21(8):1055. https:\/\/doi.org\/10.3390\/molecules21081055.","journal-title":"Molecules"},{"issue":"7","key":"4028_CR30","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","volume":"129","author":"BD Manning","year":"2007","unstructured":"Manning BD, Cantley LC. AKT\/PKB signaling: navigating downstream. Cell. 2007;129(7):1261\u201374. https:\/\/doi.org\/10.1016\/j.cell.2007.06.009.","journal-title":"Cell"},{"key":"4028_CR31","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2147\/OTT.S200317","volume":"13","author":"D Liu","year":"2020","unstructured":"Liu D, Yang Y, Yan A, Yang Y. SPOCD1 accelerates ovarian cancer progression and inhibits cell apoptosis via the PI3K\/AKT pathway. Onco Targets Ther. 2020;13:351\u20139. https:\/\/doi.org\/10.2147\/OTT.S200317.","journal-title":"Onco Targets Ther"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04028-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-04028-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04028-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T01:03:21Z","timestamp":1760490201000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-04028-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4028"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-04028-1","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"18 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committees of The Fifth Affiliated Hospital, Southern Medical University(Approval Number: 2024-MNWK-K-004), and conducted in accordance with the Declaration of Helsinki (as revised in 2013).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"371"}}